Janux Therapeutics JANX
NASDAQ JANX
$16.69 -0.37 (-2.20%)
As of: Oct 23, 2026 · 2:47 PM EDT

Janux Therapeutics (JANX) Net Debt Issuances and Repayments (2021)

Updated

Analysis

Janux Therapeutics (JANX) Net Debt Issuances and Repayments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,124.59 Bn 1,093.18 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.91 Bn 554.77 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn -2.00 Bn
4 Merck 357.53 Bn 311.91 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 289.90 Bn 253.89 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.89 Bn 238.58 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.79 Bn 193.19 Bn 7.24 Bn -
8 Gilead Sciences 194.74 Bn 168.94 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn 64.00 Mn
10 Janux Therapeutics 1.05 Bn -2.83 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -56.00 Mn
Mar 31, 2021 56.00 Mn
API Access

Janux Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=JANX&period=max&api_key=YOUR_API_KEY